Market Overview

Scott Bauer's Gilead Sciences Trade

Share:
Scott Bauer's Gilead Sciences Trade

Speaking on Bloomberg Markets, Scott Bauer, a senior market strategist at Trading Advantage, suggested that investors should consider buying a call spread in Gilead Sciences, Inc. (NASDAQ: GILD).

Related Link: Gilead Gets European CHMP's Positive Opinion On Its Type II Variation Application For Truvada

Bauer wants to buy the July 29 expiry, 88 strike call and sell the July 29 expiry, 92 strike call for a total of $1.25. The trade breaks even at $89.25 or 3.12 percent higher from the current price and Bauer can maximally make $2.75 if the stock jumps to $92 or higher.

Gilead is set to report earnings July 25, and the options market is currently anticipating a $5 move in either direction.

Full ratings data available on Benzinga Pro.

Did you like this article? Could it have been improved? Please email feedback@benzinga.com with the story link to let us know!

Posted-In: Biotech Earnings Health Care Previews Options Markets Media Trading Ideas Best of Benzinga

 

Related Articles (GILD)

View Comments and Join the Discussion!

Kickass Torrents Honors Its Name, Site Back Online

Barron's Picks And Pans: Pharmacy-Benefit Managers, Mortgage Insurers And More